Sellas Life Sciences Group Inc (SLS) Down 3.15% in Premarket Trading

Sellas Life Sciences Group Inc (SLS) is down Tuesday morning, with the stock losing -3.15% in pre-market trading to 1.23. SLS's short-term technical score of 28 indicates that the stock has traded less bullishly over the last month than 72% of stocks on the market. In the Biotechnology industry, which ranks 141 out of 146 industries, Sellas Life Sciences Group Inc ranks higher than 49% of stocks. Sellas Life Sciences Group Inc has fallen 21.12% over the past month, closing at $1.50 on September 19. During this period of time, the stock fell as low as $1.08 and as high as $1.90. SLS has an average analyst recommendation of Strong Buy. The company has an average price target of $6.00.

SLS has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on SLS!

See Full SLS Report

Sellas Life Sciences Group Inc has a Long-Term Technical rank of 17. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 83% of the market scoring higher. In the Biotechnology industry which is number 138 by this metric, SLS ranks better than 138% of stocks.

Important Dates for Investors in SLS:

-Sellas Life Sciences Group Inc is set to release earnings on 2023-11-13. Over the last 12 months, the company has reported EPS of $-1.45. -We do not have a set dividend date for Sellas Life Sciences Group Inc at this time. Click Here To Get The Full Report on Sellas Life Sciences Group Inc (SLS)